Mem. Benwell et al., STUDIES ON THE INFLUENCE OF NICOTINE INFUSIONS ON MESOLIMBIC DOPAMINEAND LOCOMOTOR RESPONSES TO NICOTINE, The Clinical investigator, 72(3), 1994, pp. 233-239
The present study examined the effects of constant nicotine infusions
on dopamine overflow in the nucleus accumbens and on locomotor activit
y and compared them with the changes evoked by repeated daily injectio
ns (one injection per day for 5 days) of the drug. The putative anxiol
ytic properties of nicotine have also been examined using the elevated
plus-maze test of anxiety. Repetitive daily subcutaneous injections o
f nicotine (0.4 mg/kg) enhanced (P < 0.01) the overflow of dopamine ev
oked by a challenge dose of the drug (0.4 mg/kg) and increased (P < 0.
01) its stimulatory effects on locomotor activity. The constant infusi
on of nicotine, at doses of 1 and 4 mg/kg per day, abolished (P < 0.05
) the effects of a bolus injection of nicotine on extracellular dopami
ne and attenuated (Pi < 0.01) the enhanced locomotor response evoked b
y daily pretreatment with nicotine boli. The mesolimbic dopamine respo
nse to a bolus injection of nicotine was not significantly attenuated
by nicotine infusions when the dose was reduced to 0.25 mg/kg per day.
The locomotor responses in these rats were significantly (P < 0.05) l
ess than those seen in the animals pretreated with nicotine injections
alone but were also higher (P < 0.05) than those seen in saline-treat
ed control rats given a bolus injection of nicotine. Neither the const
ant infusion (4 mg/kg per day) nor the injection of nicotine (0.4 mg/k
g) evoked an anxiolytic or anxiogenic effect in the elevated plus-maze
test. However, the nicotine infusions did abolish the locomotor stimu
lant effects of the drug in this apparatus. They also abolished the pl
asma corticosterone response to nicotine and attenuated the plasma cor
ticosterone response to the maze. The data suggest that constant infus
ions of nicotine, at doses of 1 mg/kg per day or more, may cause desen
sitisation of the nicotinic receptors which mediate the stimulatory ef
fects of the drug on mesolimbic dopamine release and locomotor activit
y. The data also suggest that the receptors which mediate the increase
in plasma corticosterone, seen in animals given nicotine boli, may al
so be desensitised by nicotine infusions, and that these receptors may
be implicated in the adrenocortical response to anxiogenic stimuli.